SCHEMBL3118199

SCHEMBL3118199

COc1ccc2c(=O)[nH]c(C#N)c(-c3ccccc3F)c2c1

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 4/20 0.45
ALDH1A1 P00352 2/20 0.45
NPC1 O15118 2/20 0.45
RAB9A P51151 2/20 0.45
MAPT P10636 2/20 0.45
GAA P10253 1/20 0.45
KCNA5 P22460 5/20 0.42
KCNH2 Q12809 4/20 0.42
PARP15 Q460N3 2/20 0.41
PARP10 Q53GL7 2/20 0.41
PARP14 Q460N5 1/20 0.41
TNKS2 Q9H2K2 1/20 0.41
PARP2 Q9UGN5 1/20 0.41
HPGD P15428 1/20 0.38
SMN1; SMN2 Q16637 1/20 0.38
ABCG2 Q9UNQ0 1/20 0.38
PDE9A O76083 1/20 0.38
LMNA P02545 2/20 0.37
HSD17B10 Q99714 1/20 0.37
MEN1 O00255 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11625815 0.84 ALDH1A1 (0.47) KDM4EALDH1A1NPC1RAB9AMAPT
SCHEMBL29773341 0.83 KCNA5 (0.53) KDM4EALDH1A1GAAKCNA5KCNH2
SCHEMBL3116031 0.83 KCNA5 (0.53) KDM4EALDH1A1GAAKCNA5KCNH2
SCHEMBL3114929 0.81 KCNA5 (0.61) KDM4EALDH1A1GAAKCNA5KCNH2
SCHEMBL3627255 0.80 MAPK14 (0.47) KDM4EALDH1A1MAPTGAAKCNA5
SCHEMBL3125470 0.79 NPC1 (0.44) KDM4EALDH1A1NPC1RAB9AMAPT
SCHEMBL3621355 0.76 KCNA5 (0.46) KDM4EALDH1A1GAAKCNA5KCNH2
SCHEMBL1384181 0.76 KCNA5 (0.51) KDM4EALDH1A1NPC1RAB9AMAPT
SCHEMBL3620771 0.75 KCNA5 (0.52) KDM4EALDH1A1NPC1RAB9AMAPT
SCHEMBL3617443 0.73 KCNA5 (0.76) KDM4EALDH1A1NPC1RAB9AMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7763614-B2 Isoquinoline potassium channel inhibitors MERCK SHARP & DOHME CORP. (US) 2010-07-27 US claimed
US-20070054892-A1 Isoquinoline potassium channel inhibitors MERCK SHARP & DOHME CORP. 2007-03-08 US claimed
US-7691879-B2 Isoquinoline potassium channel inhibitors MERCK SHARP & DOHME CORP. (US) 2010-04-06 US disclosed
US-20060276450-A1 Isoquinoline potassium channel inhibitors MERCK SHARP & DOHME CORP. 2006-12-07 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060276450-A1 Isoquinoline potassium channel inhibitors KCNQ1, KCNQ2, KCNJ2 KDM4E 811/4885ALDH1A1 2360/4885NPC1 484/4885
US-20070054892-A1 Isoquinoline potassium channel inhibitors KCNQ1, KCNQ2, KCNQ5 KDM4E 856/4885ALDH1A1 1553/4885NPC1 490/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.